Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001
YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017
The role of serum IL6 in stable COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018
High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Elevation of plasma cystatin C levels in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002
PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021